7-66629016-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_153033.5(KCTD7):c.-49C>T variant causes a 5 prime UTR premature start codon gain change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000909 in 1,473,840 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.00016 ( 0 hom., cov: 30)
Exomes 𝑓: 0.000082 ( 2 hom. )
Consequence
KCTD7
NM_153033.5 5_prime_UTR_premature_start_codon_gain
NM_153033.5 5_prime_UTR_premature_start_codon_gain
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.203
Genes affected
KCTD7 (HGNC:21957): (potassium channel tetramerization domain containing 7) This gene encodes a member of the potassium channel tetramerization domain-containing protein family. Family members are identified on a structural basis and contain an amino-terminal domain similar to the T1 domain present in the voltage-gated potassium channel. Mutations in this gene have been associated with progressive myoclonic epilepsy-3. Alternative splicing results in multiple transcript variants.[provided by RefSeq, Jan 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.75).
BP6
Variant 7-66629016-C-T is Benign according to our data. Variant chr7-66629016-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 138056.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population eas. gnomad4 allele frequency = 0.000165 (25/151894) while in subpopulation EAS AF= 0.00175 (9/5156). AF 95% confidence interval is 0.00091. There are 0 homozygotes in gnomad4. There are 9 alleles in male gnomad4 subpopulation. Median coverage is 30. This position pass quality control queck.
BS2
High Homozygotes in GnomAdExome4 at 2 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KCTD7 | NM_153033.5 | c.-49C>T | 5_prime_UTR_premature_start_codon_gain_variant | 1/4 | ENST00000639828.2 | NP_694578.1 | ||
KCTD7 | NM_153033.5 | c.-49C>T | 5_prime_UTR_variant | 1/4 | ENST00000639828.2 | NP_694578.1 | ||
KCTD7 | NM_001167961.2 | c.-49C>T | 5_prime_UTR_premature_start_codon_gain_variant | 1/5 | NP_001161433.1 | |||
KCTD7 | NM_001167961.2 | c.-49C>T | 5_prime_UTR_variant | 1/5 | NP_001161433.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KCTD7 | ENST00000639828 | c.-49C>T | 5_prime_UTR_premature_start_codon_gain_variant | 1/4 | 2 | NM_153033.5 | ENSP00000492240.1 | |||
KCTD7 | ENST00000639828 | c.-49C>T | 5_prime_UTR_variant | 1/4 | 2 | NM_153033.5 | ENSP00000492240.1 | |||
ENSG00000284461 | ENST00000503687.2 | n.-49C>T | 5_prime_UTR_premature_start_codon_gain_variant | 1/13 | 2 | ENSP00000421074.1 | ||||
ENSG00000284461 | ENST00000503687.2 | n.-49C>T | non_coding_transcript_exon_variant | 1/13 | 2 | ENSP00000421074.1 | ||||
ENSG00000284461 | ENST00000503687.2 | n.-49C>T | 5_prime_UTR_variant | 1/13 | 2 | ENSP00000421074.1 |
Frequencies
GnomAD3 genomes AF: 0.000165 AC: 25AN: 151786Hom.: 0 Cov.: 30
GnomAD3 genomes
AF:
AC:
25
AN:
151786
Hom.:
Cov.:
30
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000117 AC: 11AN: 93704Hom.: 0 AF XY: 0.000191 AC XY: 10AN XY: 52442
GnomAD3 exomes
AF:
AC:
11
AN:
93704
Hom.:
AF XY:
AC XY:
10
AN XY:
52442
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000825 AC: 109AN: 1321946Hom.: 2 Cov.: 27 AF XY: 0.0000859 AC XY: 56AN XY: 652064
GnomAD4 exome
AF:
AC:
109
AN:
1321946
Hom.:
Cov.:
27
AF XY:
AC XY:
56
AN XY:
652064
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000165 AC: 25AN: 151894Hom.: 0 Cov.: 30 AF XY: 0.000121 AC XY: 9AN XY: 74264
GnomAD4 genome
AF:
AC:
25
AN:
151894
Hom.:
Cov.:
30
AF XY:
AC XY:
9
AN XY:
74264
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | Mar 05, 2014 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Progressive myoclonic epilepsy type 3 Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 12, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at